Bone Targeting Agents in Patients with Prostate Cancer: General Toxicities and Osteonecrosis of the Jaw

Introduction: Bone metastases are the most frequent site of secondary localization of prostate cancer (PCa) and are present in about 90% of cases of advanced disease. Consequently, an adequate management of bone involvement is of pivotal importance in the therapeutic approach and skeletal-related ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Mollica, Veronica, Nuvola, Giacomo, Tassinari, Elisa, Nigro, Maria Concetta, Marchetti, Andrea, Rosellini, Matteo, Rizzo, Alessandro, Errani, Costantino, Massari, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947753/
https://www.ncbi.nlm.nih.gov/pubmed/35323342
http://dx.doi.org/10.3390/curroncol29030142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947753/
https://www.ncbi.nlm.nih.gov/pubmed/35323342
http://dx.doi.org/10.3390/curroncol29030142

Ejemplares similares